1998 …2024
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

2019

A phase II study of alisertib in children with recurrent/refractory solid tumors or leukemia: Children's Oncology Group Phase I and pilot Consortium (ADVL0921)

Mosse, Y. P., Fox, E., Teachey, D. T., Reid, J. M., Safgren, S. L., Carol, H., Lock, R. B., Houghton, P. J., Smith, M. A., Hall, D., Barkauskas, D. A., Krailo, M., Voss, S. D., Berg, S. L., Blaney, S. M. & Weigel, B. J., Jun 1 2019, In : Clinical Cancer Research. 25, 11, p. 3229-3238 10 p.

Research output: Contribution to journalArticle

Open Access
Leukemia
Aurora Kinase A
Neoplasms
Pharmacokinetics
Pharmacogenetics

Identification of aggressive Gardner syndrome phenotype associated with a de novo APC variant, c.4666dup

Kiessling, P., Dowling, E., Huang, Y., Ho, M. L., Balakrishnan, K., Weigel, B. J., Edward Highsmith, W., Niu, Z. & Schimmenti, L. A., Jan 1 2019, In : Cold Spring Harbor Molecular Case Studies. 5, 2, a003640.

Research output: Contribution to journalArticle

Open Access
Gardner Syndrome
Tissue
Phenotype
Tooth Abnormalities
APC Genes
2 Citations (Scopus)

The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group

Malempati, S., Weigel, B. J., Chi, Y. Y., Tian, J., Anderson, J. R., Parham, D. M., Teot, L. A., Rodeberg, D. A., Yock, T. I., Shulkin, B. L., Spunt, S. L., Meyer, W. H. & Hawkins, D. S., Jan 15 2019, In : Cancer. 125, 2, p. 290-297 8 p.

Research output: Contribution to journalArticle

temozolomide
Rhabdomyosarcoma
Drug Therapy
irinotecan
Vincristine
2018
2 Citations (Scopus)

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

Chuk, M. K., Widemann, B. C., Minard, C. G., Liu, X., Kim, A. R., Bernhardt, M. B., Kudgus, R. A., Reid, J. M., Voss, S. D., Blaney, S., Fox, E. & Weigel, B. J., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27077.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Proteinuria
Fatigue
4 Citations (Scopus)

A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)

Schafer, E. S., Rau, R. E., Berg, S., Liu, X., Minard, C. G., D'Adamo, D., Scott, R., Reyderman, L., Martinez, G., Devarajan, S., Reid, J. M., Fox, E., Weigel, B. J. & Blaney, S. M., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27066.

Research output: Contribution to journalArticle

eribulin
Microtubules
Pharmacokinetics
Neutropenia
Neoplasms

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group phase 1 and pilot consortium trial (ADVL1315)

Geller, J. I., Fox, E., Turpin, B. K., Goldstein, S. L., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Berg, S. L. & Weigel, B. J., Dec 1 2018, In : Cancer. 124, 23, p. 4548-4555 8 p.

Research output: Contribution to journalArticle

Open Access
Vascular Endothelial Growth Factor Receptor
Protein-Tyrosine Kinases
Neoplasms
Pharmacokinetics
Hypertension
6 Citations (Scopus)

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Cole, P. D., McCarten, K. M., Pei, Q., Spira, M., Metzger, M. L., Drachtman, R. A., Horton, T. M., Bush, R., Blaney, S. M., Weigel, B. J. & Kelly, K. M., Sep 1 2018, In : The Lancet Oncology. 19, 9, p. 1229-1238 10 p.

Research output: Contribution to journalArticle

gemcitabine
Hodgkin Disease
Young Adult
Pediatrics
Recurrence
4 Citations (Scopus)

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Norris, R. E., Fox, E., Reid, J. M., Ralya, A., Liu, X. W., Minard, C. & Weigel, B. J., May 1 2018, In : Pediatric Blood and Cancer. 65, 5, e26944.

Research output: Contribution to journalArticle

Neoplasms
Maximum Tolerated Dose
Pharmacokinetics
Antibodies, Monoclonal, Humanized
Ewing's Sarcoma
2017
3 Citations (Scopus)

A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)

Geller, J. I., Perentesis, J. P., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Fox, E., Blaney, S. M. & Weigel, B. J., Nov 1 2017, In : Pediatric Blood and Cancer. 64, 11, e26565.

Research output: Contribution to journalArticle

Open Access
Pharmacokinetics
Neoplasms
Proto-Oncogene Proteins c-met
Food
Powders
6 Citations (Scopus)

A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)

Rheingold, S. R., Tasian, S. J., Whitlock, J. A., Teachey, D. T., Borowitz, M. J., Liu, X., Minard, C. G., Fox, E., Weigel, B. J. & Blaney, S. M., May 1 2017, In : British Journal of Haematology. 177, 3, p. 467-474 8 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Phosphatidylinositol 3-Kinase
Sirolimus
8 Citations (Scopus)

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium

Balis, F. M., Thompson, P. A., Mosse, Y. P., Blaney, S. M., Minard, C. G., Weigel, B. J. & Fox, E., Jan 1 2017, In : Cancer chemotherapy and pharmacology. 79, 1, p. 181-187 7 p.

Research output: Contribution to journalArticle

Open Access
Pharmacokinetics
Oncology
Tumors
Neoplasms
Anaplastic Large-Cell Lymphoma
9 Citations (Scopus)

Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group

Rudzinski, E. R., Anderson, J. R., Chi, Y. Y., Gastier-Foster, J. M., Astbury, C., Barr, F. G., Skapek, S. X., Hawkins, D. S., Weigel, B. J., Pappo, A., Meyer, W. H., Arnold, M. A., Teot, L. A. & Parham, D. M., Dec 1 2017, In : Pediatric Blood and Cancer. 64, 12, e26645.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Alveolar Rhabdomyosarcoma
Histology
Embryonal Rhabdomyosarcoma
Disease-Free Survival
11 Citations (Scopus)

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials

London, W. B., Bagatell, R., Weigel, B. J., Fox, E., Guo, D., Van Ryn, C., Naranjo, A. & Park, J. R., Dec 15 2017, In : Cancer. 123, 24, p. 4914-4923 10 p.

Research output: Contribution to journalArticle

Neuroblastoma
Disease-Free Survival
Disease Progression
Recurrence
Survival
4 Citations (Scopus)

Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group

Gupta, A. A., Chi, Y. Y., Anderson, J. R., Lyden, E., Weigel, B., Arndt, C., Meyer, W. H., Rosenberg, A. & Hawkins, D. S., Sep 1 2017, In : Pediatric Blood and Cancer. 64, 9, e26479.

Research output: Contribution to journalArticle

Open Access
Rhabdomyosarcoma
Disease-Free Survival
Drug Therapy
Alveolar Rhabdomyosarcoma
Confidence Intervals
1 Citation (Scopus)

Pediatric phase I trial and pharmacokinetic study of trebananib in relapsed solid tumors, including primary tumors of the central nervous system ADVL1115: A children's oncology group phase I consortium report

Leary, S. E. S., Park, J. R., Reid, J. M., Ralya, A. T., Baruchel, S., Wu, B., Roberts, T. P. L., Liu, X., Minard, C. G., Fox, E., Weigel, B. & Blaney, S., Oct 15 2017, In : Clinical Cancer Research. 23, 20, p. 6062-6070 9 p.

Research output: Contribution to journalArticle

Central Nervous System Neoplasms
Pharmacokinetics
Pediatrics
Neoplasms
Angiogenic Proteins
56 Citations (Scopus)

Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: A Children’s Oncology Group study

Mossé, Y. P., Voss, S. D., Lim, M. S., Rolland, D., Minard, C. G., Fox, E., Adamson, P., Wilner, K., Blaney, S. M. & Weigel, B. J., Oct 1 2017, In : Journal of Clinical Oncology. 35, 28, p. 3215-3221 7 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Pediatrics
Neoplasms
crizotinib
Therapeutics
2016
1 Citation (Scopus)
Myeloid Sarcoma
Drug Therapy
Acute Myeloid Leukemia
Therapeutics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the Children's Oncology Group Phase i Consortium

Voss, S. D., Glade-Bender, J., Spunt, S. L., DuBois, S. G., Widemann, B. C., Park, J. R., Leary, S. E. S., Nelson, M. D., Adamson, P. C., Blaney, S. M. & Weigel, B. J., Jan 1 2016, In : World review of nutrition and dietetics. 114, p. 14-15 2 p.

Research output: Contribution to journalComment/debate

growth plate
Growth Plate
Pediatrics
therapeutics
neoplasms
49 Citations (Scopus)

Intensive multiagent therapy, including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/cyclophosphamide, irinotecan, and radiation, in patientswith high-risk rhabdomyosarcoma: A report from the children's oncology group

Weigel, B. J., Lyden, E., Anderson, J. R., Meyer, W. H., Parham, D. M., Rodeberg, D. A., Michalski, J. M., Hawkins, D. S. & Arndt, C. A. S., Jan 10 2016, In : Journal of Clinical Oncology. 34, 2, p. 117-122 6 p.

Research output: Contribution to journalArticle

irinotecan
Ifosfamide
Rhabdomyosarcoma
Vincristine
Etoposide
32 Citations (Scopus)

Outcome of patients with recurrent osteosarcoma enrolled in seven phase II trials through Children's Cancer Group, pediatric oncology Group, and Children's Oncology Group: Learning from the past to move forward

Lagmay, J. P., Krailo, M. D., Dang, H., Kim, A. R., Hawkins, D. S., Beaty, O., Widemann, B. C., Zwerdling, T., Bomgaars, L., Langevin, A. M., Grier, H. E., Weigel, B. J., Blaney, S. M., Gorlick, R. & Janeway, K. A., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 3031-3038 8 p.

Research output: Contribution to journalArticle

Osteosarcoma
Disease-Free Survival
Learning
Pediatrics
Neoplasms
2015
39 Citations (Scopus)

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

Loh, M. L., Tasian, S. K., Rabin, K. R., Brown, P., Magoon, D., Reid, J. M., Chen, X., Ahern, C. H., Weigel, B. J. & Blaney, S. M., Oct 1 2015, In : Pediatric Blood and Cancer. 62, 10, p. 1717-1724 8 p.

Research output: Contribution to journalArticle

Leukemia
Neoplasms
Pharmacokinetics
Hematologic Neoplasms
S 6
12 Citations (Scopus)

A phase I study of cixutumumab (IMC-A12) in combination with temsirolimus (CCI-779) in children with recurrent solid tumors: A Children's Oncology Group phase I consortium report

Fouladi, M., Perentesis, J. P., Wagner, L. M., Vinks, A. A., Reid, J. M., Ahern, C., Thomas, G., Mercer, C. A., Krueger, D. A., Houghton, P. J., Doyle, L. A., Chen, H., Weigel, B. & Blaney, S. M., Apr 1 2015, In : Clinical Cancer Research. 21, 7, p. 1558-1565 8 p.

Research output: Contribution to journalArticle

Neoplasms
Pharmacokinetics
Area Under Curve
Blood Cells
temsirolimus
13 Citations (Scopus)

A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: A Children's Oncology Group Phase I Consortium report

Kolb, E. A., Sampson, V., Stabley, D., Walter, A., Sol-Church, K., Cripe, T., Hingorani, P., Ahern, C. H., Weigel, B. J., Zwiebel, J. & Blaney, S. M., May 1 2015, In : Pediatric Blood and Cancer. 62, 5, p. 751-758 8 p.

Research output: Contribution to journalArticle

Cyclophosphamide
Neoplasms
Saliva
Viruses
Viremia
12 Citations (Scopus)

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium

Voss, S. D., Glade-Bender, J., Spunt, S. L., Dubois, S. G., Widemann, B. C., Park, J. R., Leary, S. E. S., Nelson, M. D., Adamson, P. C., Blaney, S. M. & Weigel, B. J., Jan 1 2015, In : Pediatric Blood and Cancer. 62, 1, p. 45-51 7 p.

Research output: Contribution to journalArticle

Growth Plate
Pediatrics
Neoplasms
Therapeutics
Vascular Endothelial Growth Factor A
24 Citations (Scopus)

Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group

Kim, A., Widemann, B. C., Krailo, M., Jayaprakash, N., Fox, E., Weigel, B. & Blaney, S. M., Sep 1 2015, In : Pediatric Blood and Cancer. 62, 9, p. 1562-1566 5 p.

Research output: Contribution to journalArticle

Young Adult
Wilms Tumor
Rhabdomyosarcoma
Neoplasms
Hepatocellular Carcinoma
42 Citations (Scopus)

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

Wagner, L. M., Fouladi, M., Ahmed, A., Krailo, M. D., Weigel, B., Dubois, S. G., Doyle, L. A., Chen, H. & Blaney, S. M., Mar 1 2015, In : Pediatric Blood and Cancer. 62, 3, p. 440-444 5 p.

Research output: Contribution to journalArticle

Sarcoma
Young Adult
Pediatrics
Growth Factor Receptors
Sirolimus
18 Citations (Scopus)

Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: A report of the Children's Oncology Group

Burke, M. J., Ahern, C., Weigel, B. J., Poirier, J. T., Rudin, C. M., Chen, Y., Cripe, T. P., Bernhardt, M. B. & Blaney, S. M., May 1 2015, In : Pediatric Blood and Cancer. 62, 5, p. 743-750 8 p.

Research output: Contribution to journalArticle

Viruses
Neuroblastoma
Neoplasms
Cyclophosphamide
Lymphopenia
2014
26 Citations (Scopus)

A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study

Fouladi, M., Perentesis, J. P., Phillips, C. L., Leary, S., Reid, J. M., Mcgovern, R. M., Ingle, A. M., Ahern, C. H., Ames, M. M., Houghton, P., Doyle, L. A., Weigel, B. & Blaney, S. M., Jan 1 2014, In : Pediatric Blood and Cancer. 61, 7, p. 1246-1251 6 p.

Research output: Contribution to journalArticle

Appointments and Schedules
Exanthema
Neoplasms
Pharmacokinetics
Ependymoma
45 Citations (Scopus)

A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia

Burke, M. J., Lamba, J. K., Pounds, S., Cao, X., Ghodke-Puranik, Y., Lindgren, B. R., Weigel, B. J., Verneris, M. R. & Miller, J. S., Jan 1 2014, In : American Journal of Hematology. 89, 9, p. 889-895 7 p.

Research output: Contribution to journalArticle

decitabine
Combination Drug Therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Methylation
Neutropenia
48 Citations (Scopus)

Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study

Bagatell, R., Norris, R., Ingle, A. M., Ahern, C., Voss, S., Fox, E., Little, A. R., Weigel, B. J., Adamson, P. C. & Blaney, S., Jan 1 2014, In : Pediatric Blood and Cancer. 61, 5, p. 833-839 7 p.

Research output: Contribution to journalArticle

irinotecan
temozolomide
Young Adult
Maximum Tolerated Dose
Neoplasms
77 Citations (Scopus)

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: A report from the Children's Oncology Group

Weigel, B., Malempati, S., Reid, J. M., Voss, S. D., Cho, S. Y., Chen, H. X., Krailo, M., Villaluna, D., Adamson, P. C. & Blaney, S. M., Mar 1 2014, In : Pediatric Blood and Cancer. 61, 3, p. 452-456 5 p.

Research output: Contribution to journalArticle

Young Adult
Neoplasms
Neuroblastoma
Insulin-Like Growth Factor Binding Protein 3
Rhabdomyosarcoma
58 Citations (Scopus)

Toward a drug development path that targets metastatic progression in osteosarcoma

Khanna, C., Fan, T. M., Gorlick, R., Helman, L. J., Kleinerman, E. S., Adamson, P. C., Houghton, P. J., Tap, W. D., Welch, D. R., Steeg, P. S., Merlino, G., Sorensen, P. H. B., Meltzer, P., Kirsch, D. G., Janeway, K. A., Weigel, B., Randall, L., Withrow, S. J., Paoloni, M., Kaplan, R. & 12 others, Teicher, B. A., Seibel, N. L., Smith, M., Üren, A., Patel, S. R., Trent, J., Savage, S. A., Mirabello, L., Reinke, D., Barkaukas, D. A., Krailo, M. & Bernstein, M., Aug 15 2014, In : Clinical Cancer Research. 20, 16, p. 4200-4209 10 p.

Research output: Contribution to journalReview article

Osteosarcoma
Neoplasm Metastasis
Pharmaceutical Preparations
Expert Testimony
Neoplasms
2013
31 Citations (Scopus)

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Hummel, T. R., Wagner, L., Ahern, C., Fouladi, M., Reid, J. M., Mcgovern, R. M., Ames, M. M., Gilbertson, R. J., Horton, T., Ingle, A. M., Weigel, B. J. & Blaney, S. M., Sep 1 2013, In : Pediatric Blood and Cancer. 60, 9, p. 1452-1457 6 p.

Research output: Contribution to journalArticle

temozolomide
Spinal Cord Neoplasms
Pediatrics
Brain
Leukopenia
26 Citations (Scopus)

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: A children's oncology group phase I consortium study (ADVL1112)

Thompson, P. A., Drissi, R., Muscal, J. A., Panditharatna, E., Fouladi, M., Ingle, A. M., Ahern, C. H., Reid, J. M., Lin, T., Weigel, B. J. & Blaney, S. M., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6578-6584 7 p.

Research output: Contribution to journalArticle

Telomerase
Neoplasms
Pharmacokinetics
Lymphopenia
Ewing's Sarcoma
40 Citations (Scopus)

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

Muscal, J. A., Thompson, P. A., Horton, T. M., Ingle, A. M., Ahern, C. H., McGovern, R. M., Reid, J. M., Ames, M. M., Espinoza-Delgado, I., Weigel, B. J. & Blaney, S. M., Mar 1 2013, In : Pediatric Blood and Cancer. 60, 3, p. 390-395 6 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Neoplasms
Maximum Tolerated Dose
Anorexia
Nausea
4 Citations (Scopus)

Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma

Charbonneau, B., Vogel, R. I., Manivel, J. C., Rizzardi, A., Schmechel, S. C., Ognjanovic, S., Subramanian, S., Largaespada, D. A. & Weigel, B. J., Sep 1 2013, In : Human pathology. 44, 9, p. 1918-1926 9 p.

Research output: Contribution to journalArticle

Synovial Sarcoma
Disease-Free Survival
Neoplasms
Tumor Biomarkers
Sarcoma
81 Citations (Scopus)

Phase i pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: A children's oncology group phase i consortium report

Glade Bender, J. L., Lee, A., Reid, J. M., Baruchel, S., Roberts, T., Voss, S. D., Wu, B., Ahern, C. H., Ingle, A. M., Harris, P., Weigel, B. J. & Blaney, S. M., Aug 20 2013, In : Journal of Clinical Oncology. 31, 24, p. 3034-3043 10 p.

Research output: Contribution to journalArticle

Sarcoma
Pharmacokinetics
Tablets
Maximum Tolerated Dose
Neoplasms
353 Citations (Scopus)

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: A Children's Oncology Group phase 1 consortium study

Mossé, Y. P., Lim, M. S., Voss, S. D., Wilner, K., Ruffner, K., Laliberte, J., Rolland, D., Balis, F. M., Maris, J. M., Weigel, B. J., Ingle, A. M., Ahern, C., Adamson, P. C. & Blaney, S. M., May 1 2013, In : The Lancet Oncology. 14, 6, p. 472-480 9 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Pediatrics
Safety
Neoplasms
Neuroblastoma
2012
18 Citations (Scopus)

A phase I trial and pharmacokinetic study of aflibercept (VEGF trap) in children with refractory solid tumors: A Children's Oncology Group phase I consortium report

Bender, J. G., Blaney, S. M., Borinstein, S., Reid, J. M., Baruchel, S., Ahern, C., Ingle, A. M., Yamashiro, D. J., Chen, A., Weigel, B., Adamson, P. C. & Park, J. R., Sep 15 2012, In : Clinical Cancer Research. 18, 18, p. 5081-5089 9 p.

Research output: Contribution to journalArticle

Pharmacokinetics
Maximum Tolerated Dose
Neoplasms
Vascular Endothelial Growth Factor A
Clear Cell Sarcoma
72 Citations (Scopus)

A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: A Children's Oncology Group Phase I Consortium report

Widemann, B. C., Kim, A. R., Fox, E., Baruchel, S., Adamson, P. C., Ingle, A. M., Bender, J. G., Burke, M., Weigel, B., Stempak, D., Balis, F. M. & Blaney, S. M., Nov 1 2012, In : Clinical Cancer Research. 18, 21, p. 6011-6022 12 p.

Research output: Contribution to journalArticle

Leukemia
Pharmacokinetics
Maximum Tolerated Dose
Neoplasms
Aspartate Aminotransferases
68 Citations (Scopus)

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: A children's oncology group phase I consortium study

Mossé, Y. P., Greengard, E. G., Fox, E., Teachey, D. T., Maris, J. M., Weigel, B. J., Adamson, P. C., Ingle, M. A., Ahern, C. H. & Blaney, S. M., Nov 1 2012, In : Clinical Cancer Research. 18, 21, p. 6058-6064 7 p.

Research output: Contribution to journalArticle

Aurora Kinase A
Appointments and Schedules
Pharmacokinetics
Pediatrics
Hand-Foot Syndrome
110 Citations (Scopus)

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: A report from the Children's Oncology Group

Malempati, S., Weigel, B. J., Ingle, A. M., Ahern, C. H., Carroll, J. M., Roberts, C. T., Reid, J. M., Schmechel, S., Voss, S. D., Cho, S. Y., Chen, H. X., Krailo, M. D., Adamson, P. C. & Blaney, S. M., Jan 20 2012, In : Journal of Clinical Oncology. 30, 3, p. 256-262 7 p.

Research output: Contribution to journalArticle

Ewing's Sarcoma
Pharmacokinetics
Pediatrics
Neoplasms
IGF Type 1 Receptor
25 Citations (Scopus)
Toll-Like Receptor 7
Hematologic Neoplasms
Innate Immunity
Aptitude
Toll-Like Receptors
2011
13 Citations (Scopus)
Cell Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Disease-Free Survival
Tissue Donors
303 Citations (Scopus)

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia

Zhou, Q., Munger, M. E., Veenstra, R. G., Weigel, B. J., Hirashima, M., Munn, D. H., Murphy, W. J., Azuma, M., Anderson, A. C., Kuchroo, V. K. & Blazar, B. R., Apr 28 2011, In : Blood. 117, 17, p. 4501-4510 10 p.

Research output: Contribution to journalArticle

T-cells
Acute Myeloid Leukemia
T-Lymphocytes
Phenotype
Galectin 3
2010
12 Citations (Scopus)

Killing the killer: Natural killer cells to treat Ewing's sarcoma

Ahn, Y. O., Weigel, B. J. & Verneris, M. R., Aug 1 2010, In : Clinical Cancer Research. 16, 15, p. 3819-3821 3 p.

Research output: Contribution to journalComment/debate

Ewing's Sarcoma
Natural Killer Cells
Neoplasms
153 Citations (Scopus)

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia

Zhou, Q., Munger, M. E., Highfill, S. L., Tolar, J., Weigel, B. J., Riddle, M., Sharpe, A. H., Vallera, D. A., Azuma, M., Levine, B. L., June, C. H., Murphy, W. J., Munn, D. H. & Blazar, B. R., Oct 7 2010, In : Blood. 116, 14, p. 2484-2493 10 p.

Research output: Contribution to journalArticle

T-cells
Cytotoxic T-Lymphocytes
Regulatory T-Lymphocytes
Acute Myeloid Leukemia
Tumors
35 Citations (Scopus)
Toll-Like Receptor 7
Uterine Cervical Neoplasms
Ovarian Neoplasms
Appointments and Schedules
Breast Neoplasms
2009
20 Citations (Scopus)
Philadelphia Chromosome
Cell Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Pediatrics
Transplants
9 Citations (Scopus)

Cutaneous pseudolymphoma: An unusual presentation of a scalp mass

Nnebe, N. V., Woon, C., Haines, S. J., Dayton, V. & Weigel, B. J., Feb 1 2009, In : Pediatric Blood and Cancer. 52, 2, p. 283-285 3 p.

Research output: Contribution to journalArticle

Pseudolymphoma
Scalp
Skin
Lymphocytes
Antigens